Eledon Pharmaceuticals, Inc. (ELDN) Social Stream
ELEDON PHARMACEUTICALS INC (ELDN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ELEDON PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-18 | 4 | $39 | $22 | $30.8 | $1.77 | 1640.11% |
| 2022-03-25 | 4 | $39 | $22 | $28.8 | $1.77 | 1527.12% |
| 2022-05-03 | 5 | $39 | $22 | $28.8 | $1.77 | 1527.12% |
| 2022-05-16 | 5 | $39 | $15 | $26.8 | $1.77 | 1414.12% |
| 2022-11-15 | 4 | $39 | $15 | $25.4 | $1.77 | 1335.03% |
| 2023-02-08 | 5 | $39 | $6 | $19.4 | $1.77 | 996.05% |
| 2023-04-03 | 5 | $39 | $6 | $18.2 | $1.77 | 928.25% |
| 2023-05-11 | 4 | $39 | $7 | $20.75 | $1.77 | 1072.32% |
| 2023-05-31 | 5 | $39 | $7 | $20.75 | $1.77 | 1072.32% |
| 2023-08-10 | 5 | $39 | $7 | $18.4 | $1.77 | 939.55% |
| 2023-08-11 | 5 | $39 | $7 | $17.8 | $1.77 | 905.65% |
| 2023-09-27 | 6 | $39 | $7 | $16.5 | $1.77 | 832.2% |
| 2023-11-10 | 6 | $39 | $7 | $14.5 | $1.77 | 719.21% |
| 2023-11-13 | 6 | $39 | $7 | $15.6 | $1.77 | 781.36% |
The Trend in the Analyst Price Target
Over the past 15 months, ELDN's average price target has gone down $9.8.
ELDN reports an average of 906.52% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-26 | 5 | 39 | 7 | 20.75 | 1.849 | 1022.23% |
| 2023-05-31 | 5 | 39 | 7 | 18.40 | 2.100 | 776.19% |
| 2023-10-24 | 6 | 39 | 7 | 14.50 | 1.340 | 982.09% |
| 2023-10-25 | 6 | 39 | 7 | 14.50 | 1.430 | 913.99% |
| 2023-11-03 | 6 | 39 | 7 | 14.50 | 1.230 | 1078.86% |
ELDN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
ELDN's average broker recommendation rating improved by 0 over the prior 13 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ELEDON PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1556.5% of that group.
- ELDN has a lower variance in analysts' estimates than -1341.01% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, ELEDON PHARMACEUTICALS INC's number of analysts covering the stock is greater than 394.91% of them.
- ELDN has a higher average analyst price target than 578.61% of Healthcare stocks.
In the Pharmaceutical Products industry, ARDX, LRMR, and SLRX are the three stocks most similar to ELEDON PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for ELDN? Use POWR Ratings for clearer insight into price direction.